Chartwell Partners is pleased to announce the recruitment of Andy Stober as Chief Manufacturing Officer for Encoded Therapeutics, a South San Francisco based precision gene therapy company. Encoded recently announced a $104M Series C financing and has been funded to date with world class venture companies including Venrock, ARCH Venture Partners, Matrix Capital Management, and…
Month: September 2019
Chartwell Partners is pleased to announce the appointment of Paula Cobb to the Board of Directors for Prothena, a clinical stage neuroscience company focused on developing therapies for some of the most debilitating neurological diseases. Paula brings a tremendous breadth of experience overseeing portfolio strategy, program management, product development and commercialization for multiple specialty and…